NCT00352079 2023-08-04BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder CancerCanadian Cancer Trials GroupPhase 3 Terminated41 enrolled
NCT00974818 2015-11-20Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer PatientsMemorial Sloan Kettering Cancer CenterPhase 3 Terminated50 enrolled 7 charts